{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:34:18Z","timestamp":1789151658365,"version":"build-2803163510"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,7]]},"DOI":"10.7759\/cureus.44852","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T12:17:16Z","timestamp":1694089036000},"source":"Crossref","is-referenced-by-count":12,"title":["Is Fibromyalgia a Fashionable Diagnosis or a Medical Mystery?"],"prefix":"10.7759","author":[{"given":"Giustino","family":"Varrassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rekatsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse","family":"Bouajina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Paladini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Coaccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Narvaez Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piercarlo","family":"Sarzi Puttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-10-102","article-title":"A patient survey of the impact of fibromyalgia and the journey to diagnosis","volume":"10","author":"Choy E","year":"2010","unstructured":"Choy E, Perrot S, Leon T, Kaplan J, Petersel D, Ginovker A, Kramer E. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res. 2010, 10:102. 10.1186\/1472-6963-10-102","journal-title":"BMC Health Serv Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/i19pig","article-title":"Fibromyalgia position paper","volume":"39","author":"Sarzi-Puttini P","year":"2021","unstructured":"Sarzi-Puttini P, Giorgi V, Atzeni F, et al.. Fibromyalgia position paper. Clin Exp Rheumatol. 2021, 39:186-93. 10.55563\/clinexprheumatol\/i19pig","journal-title":"Clin Exp Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw DJ","year":"2014","unstructured":"Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014, 311:1547-55. 10.1001\/jama.2014.3266","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2008.00188.x","article-title":"Fibromyalgia: nosography and therapeutic perspectives","volume":"8","author":"Coaccioli S","year":"2008","unstructured":"Coaccioli S, Varrassi G, Sabatini C, Marinangeli F, Giuliani M, Puxeddu A. Fibromyalgia: nosography and therapeutic perspectives. Pain Pract. 2008, 8:190-201. 10.1111\/j.1533-2500.2008.00188.x","journal-title":"Pain Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-193501000-00024","article-title":"Chronic generalized fibromyositis","volume":"101","author":"Ornsteen AM","year":"1935","unstructured":"Ornsteen AM. Chronic generalized fibromyositis. Ann Surg. 1935, 101:237-45. 10.1097\/00000658-193501000-00024","journal-title":"Ann Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4102\/sajp.v8i3.1685","article-title":"Fibrositis and non-articular rheumatism","volume":"8","author":"Graham W","year":"1954","unstructured":"Graham W. Fibrositis and non-articular rheumatism. S Afr J Physiother. 1954, 8:20-22. 10.4102\/sajp.v8i3.1685","journal-title":"S Afr J Physiother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.96","article-title":"Culture, science and the changing nature of fibromyalgia","volume":"9","author":"Wolfe F","year":"2013","unstructured":"Wolfe F, Walitt B. Culture, science and the changing nature of fibromyalgia. Nat Rev Rheumatol. 2013, 9:751-5. 10.1038\/nrrheum.2013.96","journal-title":"Nat Rev Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2012.186","article-title":"If fibromyalgia did not exist, we should have invented it. A short history of a controversial syndrome","volume":"64","author":"Perrot S","year":"2012","unstructured":"Perrot S. If fibromyalgia did not exist, we should have invented it. A short history of a controversial syndrome. Reumatismo. 2012, 64:186-93. 10.4081\/reumatismo.2012.186","journal-title":"Reumatismo"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2016.06.006","article-title":"Neurobiology of fibromyalgia and chronic widespread pain","volume":"338","author":"Sluka KA","year":"2016","unstructured":"Sluka KA, Clauw DJ. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience. 2016, 338:114-29. 10.1016\/j.neuroscience.2016.06.006","journal-title":"Neuroscience"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.09.018","article-title":"Brain glial activation in fibromyalgia - a multi-site positron emission tomography investigation","volume":"75","author":"Albrecht DS","year":"2019","unstructured":"Albrecht DS, Forsberg A, Sandstr\u00f6m A, et al.. Brain glial activation in fibromyalgia - a multi-site positron emission tomography investigation. Brain Behav Immun. 2019, 75:72-83. 10.1016\/j.bbi.2018.09.018","journal-title":"Brain Behav Immun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.98","article-title":"Fibromyalgia: from pathophysiology to therapy","volume":"7","author":"Schmidt-Wilcke T","year":"2011","unstructured":"Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol. 2011, 7:518-27. 10.1038\/nrrheum.2011.98","journal-title":"Nat Rev Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000464","article-title":"The complexities of fibromyalgia and its comorbidities","volume":"30","author":"Lichtenstein A","year":"2018","unstructured":"Lichtenstein A, Tiosano S, Amital H. The complexities of fibromyalgia and its comorbidities. Curr Opin Rheumatol. 2018, 30:94-100. 10.1097\/BOR.0000000000000464","journal-title":"Curr Opin Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1252","article-title":"Comorbid fibromyalgia: a qualitative review of prevalence and importance","volume":"22","author":"Fitzcharles MA","year":"2018","unstructured":"Fitzcharles MA, Perrot S, H\u00e4user W. Comorbid fibromyalgia: a qualitative review of prevalence and importance. Eur J Pain. 2018, 22:1565-76. 10.1002\/ejp.1252","journal-title":"Eur J Pain"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2007.09.003","article-title":"Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness","volume":"37","author":"Yunus MB","year":"2008","unstructured":"Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 2008, 37:339-52. 10.1016\/j.semarthrit.2007.09.003","journal-title":"Semin Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2008.02.021","article-title":"Somatic comorbidities of irritable bowel syndrome: a systematic analysis","volume":"64","author":"Riedl A","year":"2008","unstructured":"Riedl A, Schmidtmann M, Stengel A, Goebel M, Wisser AS, Klapp BF, M\u00f6nnikes H. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res. 2008, 64:573-82. 10.1016\/j.jpsychores.2008.02.021","journal-title":"J Psychosom Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1676090","article-title":"Fibromyalgia and irritable bowel syndrome in female pelvic pain","volume":"36","author":"Johnson CM","year":"2018","unstructured":"Johnson CM, Makai GE. Fibromyalgia and irritable bowel syndrome in female pelvic pain. Semin Reprod Med. 2018, 36:136-42. 10.1055\/s-0038-1676090","journal-title":"Semin Reprod Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/iju.13985","article-title":"Pathophysiology of interstitial cystitis","volume":"26","author":"Birder LA","year":"2019","unstructured":"Birder LA. Pathophysiology of interstitial cystitis. Int J Urol. 2019, 26:12-5. 10.1111\/iju.13985","journal-title":"Int J Urol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.06.005","article-title":"Interstitial cystitis\/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome","volume":"184","author":"Nickel JC","year":"2010","unstructured":"Nickel JC, Tripp DA, Pontari M, et al.. Interstitial cystitis\/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol. 2010, 184:1358-63. 10.1016\/j.juro.2010.06.005","journal-title":"J Urol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2010.03.006","article-title":"Relationship between fibromyalgia and obesity in pain, function, mood, and sleep","volume":"11","author":"Okifuji A","year":"2010","unstructured":"Okifuji A, Donaldson GW, Barck L, Fine PG. Relationship between fibromyalgia and obesity in pain, function, mood, and sleep. J Pain. 2010, 11:1329-37. 10.1016\/j.jpain.2010.03.006","journal-title":"J Pain"},{"key":"ref20","article-title":"Prevalence of fibromyalgia in diabetes mellitus and obesity. (Article in Italian)","volume":"94","author":"Patucchi E","year":"2003","unstructured":"Patucchi E, Fatati G, Puxeddu A, Coaccioli S. Prevalence of fibromyalgia in diabetes mellitus and obesity. (Article in Italian). Recenti Progr Med. 2003, 94:163-5.","journal-title":"Recenti Progr Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2019.06.005","article-title":"The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis","volume":"33","author":"Zhao SS","year":"2019","unstructured":"Zhao SS, Duffield SJ, Goodson NJ. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract Res Clin Rheumatol. 2019, 33:101423. 10.1016\/j.berh.2019.06.005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0892-9","article-title":"Fibromyalgia in migraine: a retrospective cohort study","volume":"19","author":"Whealy M","year":"2018","unstructured":"Whealy M, Nanda S, Vincent A, Mandrekar J, Cutrer FM. Fibromyalgia in migraine: a retrospective cohort study. J Headache Pain. 2018, 19:61. 10.1186\/s10194-018-0892-9","journal-title":"J Headache Pain"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2218-2","article-title":"The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine","volume":"32","author":"K\u00fc\u00e7\u00fck\u015fen S","year":"2013","unstructured":"K\u00fc\u00e7\u00fck\u015fen S, Gen\u00e7 E, Y\u0131lmaz H, et al.. The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine. Clin Rheumatol. 2013, 32:983-90. 10.1007\/s10067-013-2218-2","journal-title":"Clin Rheumatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-011-0377-6","article-title":"Clinical features of headache patients with fibromyalgia comorbidity","volume":"12","author":"de Tommaso M","year":"2011","unstructured":"de Tommaso M, Federici A, Serpino C, et al.. Clinical features of headache patients with fibromyalgia comorbidity. J Headache Pain. 2011, 12:629-38. 10.1007\/s10194-011-0377-6","journal-title":"J Headache Pain"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026581","article-title":"Bidirectional association between migraine and fibromyalgia: retrospective cohort analyses of two populations","volume":"9","author":"Penn IW","year":"2019","unstructured":"Penn IW, Chuang E, Chuang TY, Lin CL, Kao CH. Bidirectional association between migraine and fibromyalgia: retrospective cohort analyses of two populations. BMJ Open. 2019, 9:e026581. 10.1136\/bmjopen-2018-026581","journal-title":"BMJ Open"},{"key":"ref26","article-title":"Fibromyalgia syndrome: under-, over- and misdiagnosis","volume":"37","author":"H\u00e4user W","year":"2019","unstructured":"H\u00e4user W, Sarzi-Puttini P, Fitzcharles MA. Fibromyalgia syndrome: under-, over- and misdiagnosis. Clin Exp Rheumatol. 2019, 37:90-7.","journal-title":"Clin Exp Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/zcp5hz","article-title":"Diagnostic and therapeutic care pathway for fibromyalgia","volume":"39","author":"Sarzi-Puttini P","year":"2021","unstructured":"Sarzi-Puttini P, Giorgi V, Atzeni F, et al.. Diagnostic and therapeutic care pathway for fibromyalgia. Clin Exp Rheumatol. 2021, 39:120-7. 10.55563\/clinexprheumatol\/zcp5hz","journal-title":"Clin Exp Rheumatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2018.20.1\/whauser","article-title":"Facts and myths pertaining to fibromyalgia","volume":"20","author":"H\u00e4user W","year":"2018","unstructured":"H\u00e4user W, Fitzcharles MA. Facts and myths pertaining to fibromyalgia. Dialogues Clin Neurosci. 2018, 20:53-62. 10.31887\/DCNS.2018.20.1\/whauser","journal-title":"Dialogues Clin Neurosci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0738","article-title":"Improving the recognition and diagnosis of fibromyalgia","volume":"86","author":"Arnold LM","year":"2011","unstructured":"Arnold LM, Clauw DJ, McCarberg BH. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc. 2011, 86:457-64. 10.4065\/mcp.2010.0738","journal-title":"Mayo Clin Proc"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201902_17141","article-title":"Ozone therapy in 65 patients with fibromyalgia: an effective therapy","volume":"23","author":"Tirelli U","year":"2019","unstructured":"Tirelli U, Cirrito C, Pavanello M, Piasentin C, Lleshi A, Taibi R. Ozone therapy in 65 patients with fibromyalgia: an effective therapy. Eur Rev Med Pharmacol Sci. 2019, 23:1786-8. 10.26355\/eurrev_201902_17141","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211587","article-title":"EULAR recommendations for management of fibromyalgia","volume":"76","author":"Macfarlane GJ","year":"2017","unstructured":"Macfarlane GJ, Kronisch C, Atzeni F, et al.. EULAR recommendations for management of fibromyalgia. Ann Rheum Dis. 2017, 76:e54. 10.1136\/annrheumdis-2017-211587","journal-title":"Ann Rheum Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.071522","article-title":"EULAR evidence-based recommendations for the management of fibromyalgia syndrome","volume":"67","author":"Carville SF","year":"2008","unstructured":"Carville SF, Arendt-Nielsen L, Bliddal H, et al.. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008, 67:536-41. 10.1136\/ard.2007.071522","journal-title":"Ann Rheum Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2010.09.007","article-title":"Systematic review of the comparative effectiveness of antiepileptic drugs for fibromyalgia","volume":"12","author":"Siler AC","year":"2011","unstructured":"Siler AC, Gardner H, Yanit K, Cushman T, McDonagh M. Systematic review of the comparative effectiveness of antiepileptic drugs for fibromyalgia. J Pain. 2011, 12:407-15. 10.1016\/j.jpain.2010.09.007","journal-title":"J Pain"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012188.pub2","article-title":"Gabapentin for fibromyalgia pain in adults","volume":"1","author":"Cooper TE","year":"2017","unstructured":"Cooper TE, Derry S, Wiffen PJ, Moore RA. Gabapentin for fibromyalgia pain in adults. Cochrane Database Syst Rev. 2017, 1:CD012188. 10.1002\/14651858.CD012188.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2009.01144.x","article-title":"Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis","volume":"35","author":"Tzellos TG","year":"2010","unstructured":"Tzellos TG, Toulis KA, Goulis DG, Papazisis G, Zampeli VA, Vakfari A, Kouvelas D. Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis. J Clin Pharm Ther. 2010, 35:639-56. 10.1111\/j.1365-2710.2009.01144.x","journal-title":"J Clin Pharm Ther"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.0c00467","article-title":"Classics in chemical neuroscience: amitriptyline","volume":"12","author":"McClure EW","year":"2021","unstructured":"McClure EW, Daniels RN. Classics in chemical neuroscience: amitriptyline. ACS Chem Neurosci. 2021, 12:354-62. 10.1021\/acschemneuro.0c00467","journal-title":"ACS Chem Neurosci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.564","article-title":"More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: a meta-analysis examining six core symptoms","volume":"18","author":"Perrot S","year":"2014","unstructured":"Perrot S, Russell IJ. More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: a meta-analysis examining six core symptoms. Eur J Pain. 2014, 18:1067-80. 10.1002\/ejp.564","journal-title":"Eur J Pain"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.2015.1091726","article-title":"Amitriptyline for the treatment of fibromyalgia: a comprehensive review","volume":"15","author":"Rico-Villademoros F","year":"2015","unstructured":"Rico-Villademoros F, Slim M, Calandre EP. Amitriptyline for the treatment of fibromyalgia: a comprehensive review. Expert Rev Neurother. 2015, 15:1123-50. 10.1586\/14737175.2015.1091726","journal-title":"Expert Rev Neurother"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn MP","year":"2014","unstructured":"Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014, CD007115. 10.1002\/14651858.CD007115.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/GH9.0000000000000093","article-title":"Duloxetine: an effective treatment for fibromyalgia syndrome?","volume":"6","author":"Elahi N","year":"2023","unstructured":"Elahi N, Ellahi A. Duloxetine: an effective treatment for fibromyalgia syndrome?. IJS Global Health. 2023, 6:e93. 10.1097\/GH9.0000000000000093","journal-title":"IJS Global Health"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.52965\/001c.25532","article-title":"Milnacipran for the treatment of fibromyalgia","volume":"9","author":"Gupta H","year":"2021","unstructured":"Gupta H, Girma B, Jenkins JS, Kaufman SE, Lee CA, Kaye AD. Milnacipran for the treatment of fibromyalgia. Health Psychol Res. 2021, 9:25532. 10.52965\/001c.25532","journal-title":"Health Psychol Res"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011789","article-title":"Milnacipran for neuropathic pain in adults","volume":"2015","author":"Derry S","year":"2015","unstructured":"Derry S, Phillips T, Moore RA, Wiffen PJ. Milnacipran for neuropathic pain in adults. Cochrane Database Syst Rev. 2015, 2015:CD011789. 10.1002\/14651858.CD011789","journal-title":"Cochrane Database Syst Rev"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008244.pub3","article-title":"Milnacipran for pain in fibromyalgia in adults","volume":"2015","author":"Cording M","year":"2015","unstructured":"Cording M, Derry S, Phillips T, Moore RA, Wiffen PJ. Milnacipran for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2015, 2015:CD008244. 10.1002\/14651858.CD008244.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06129-8","article-title":"Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: an overview with network meta-analysis","volume":"41","author":"Alberti FF","year":"2022","unstructured":"Alberti FF, Becker MW, Blatt CR, Ziegelmann PK, da Silva Dal Pizzol T, Pilger D. Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: an overview with network meta-analysis. Clin Rheumatol. 2022, 41:1965-78. 10.1007\/s10067-022-06129-8","journal-title":"Clin Rheumatol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-5-48","article-title":"Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain","volume":"5","author":"Baraniuk JN","year":"2004","unstructured":"Baraniuk JN, Whalen G, Cunningham J, Clauw DJ. Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord. 2004, 5:48. 10.1186\/1471-2474-5-48","journal-title":"BMC Musculoskelet Disord"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.02.002","article-title":"Opioid use in fibromyalgia: a cautionary tale","volume":"91","author":"Goldenberg DL","year":"2016","unstructured":"Goldenberg DL, Clauw DJ, Palmer RE, Clair AG. Opioid use in fibromyalgia: a cautionary tale. Mayo Clin Proc. 2016, 91:640-8. 10.1016\/j.mayocp.2016.02.002","journal-title":"Mayo Clin Proc"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2009.01.006","article-title":"Guidelines on the management of fibromyalgia syndrome - a systematic review","volume":"14","author":"H\u00e4user W","year":"2010","unstructured":"H\u00e4user W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome - a systematic review. Eur J Pain. 2010, 14:5-10. 10.1016\/j.ejpain.2009.01.006","journal-title":"Eur J Pain"},{"key":"ref48","article-title":"Opioid use disorder","author":"Dydyk AM","year":"2023","unstructured":"Dydyk AM, Jain NK, Gupta M. Opioid use disorder. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001273","article-title":"Opioid use in fibromyalgia continues despite guidelines that do not support its efficacy or risk","volume":"27","author":"Bruce BK","year":"2021","unstructured":"Bruce BK, Allman ME, Rivera FA, et al.. Opioid use in fibromyalgia continues despite guidelines that do not support its efficacy or risk. J Clin Rheumatol. 2021, 27:187-93. 10.1097\/RHU.0000000000001273","journal-title":"J Clin Rheumatol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(03)00116-5","article-title":"Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study","volume":"114","author":"Bennett RM","year":"2003","unstructured":"Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med. 2003, 114:537-45. 10.1016\/s0002-9343(03)00116-5","journal-title":"Am J Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/art.37734","article-title":"Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels","volume":"65","author":"Younger J","year":"2013","unstructured":"Younger J, Noor N, McCue R, Mackey S. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum. 2013, 65:529-38. 10.1002\/art.37734","journal-title":"Arthritis Rheum"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines5020016","article-title":"Reduced pro-inflammatory cytokines after eight weeks of low-dose naltrexone for fibromyalgia","volume":"5","author":"Parkitny L","year":"2017","unstructured":"Parkitny L, Younger J. Reduced pro-inflammatory cytokines after eight weeks of low-dose naltrexone for fibromyalgia. Biomedicines. 2017, 5:16. 10.3390\/biomedicines5020016","journal-title":"Biomedicines"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S395457","article-title":"The safety and efficacy of low-dose naltrexone in patients with fibromyalgia: a systematic review","volume":"16","author":"Yang J","year":"2023","unstructured":"Yang J, Shin KM, Do A, et al.. The safety and efficacy of low-dose naltrexone in patients with fibromyalgia: a systematic review. J Pain Res. 2023, 16:1017-23. 10.2147\/JPR.S395457","journal-title":"J Pain Res"},{"key":"ref54","article-title":"Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial","volume":"16","author":"Yunus MB","year":"1989","unstructured":"Yunus MB, Masi AT, Aldag JC. Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial. J Rheumatol. 1989, 16:527-32.","journal-title":"J Rheumatol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.06.003","article-title":"A systematic review and mixed treatment comparison of the efficacy of pharmacological treatments for fibromyalgia","volume":"41","author":"Choy E","year":"2011","unstructured":"Choy E, Marshall D, Gabriel ZL, Mitchell SA, Gylee E, Dakin HA. A systematic review and mixed treatment comparison of the efficacy of pharmacological treatments for fibromyalgia. Semin Arthritis Rheum. 2011, 41:335-45.e6. 10.1016\/j.semarthrit.2011.06.003","journal-title":"Semin Arthritis Rheum"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1177\/17579759211016802","article-title":"Scoping health literacy in Latin America","volume":"29","author":"Arrighi E","year":"2022","unstructured":"Arrighi E, Ruiz de Castilla EM, Peres F, et al.. Scoping health literacy in Latin America. Glob Health Promot. 2022, 29:78-87. 10.1177\/17579759211016802","journal-title":"Glob Health Promot"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.10239","article-title":"Attitudes of Israeli rheumatologists to the use of medical cannabis as therapy for rheumatic disorders","volume":"7","author":"Ablin JN","year":"2016","unstructured":"Ablin JN, Elkayam O, Fitzcharles MA. Attitudes of Israeli rheumatologists to the use of medical cannabis as therapy for rheumatic disorders. Rambam Maimonides Med J. 2016, 7:e0012. 10.5041\/RMMJ.10239","journal-title":"Rambam Maimonides Med J"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00454-7","article-title":"CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain","volume":"96","author":"Clayton N","year":"2002","unstructured":"Clayton N, Marshall FH, Bountra C, O'Shaughnessy CT. CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain. 2002, 96:253-60. 10.1016\/S0304-3959(01)00454-7","journal-title":"Pain"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.336","article-title":"Brain mapping-based model of \u0394(9)-tetrahydrocannabinol effects on connectivity in the pain matrix","volume":"41","author":"Walter C","year":"2016","unstructured":"Walter C, Oertel BG, Felden L, et al.. Brain mapping-based model of \u0394(9)-tetrahydrocannabinol effects on connectivity in the pain matrix. Neuropsychopharmacology. 2016, 41:1659-69. 10.1038\/npp.2015.336","journal-title":"Neuropsychopharmacology"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1665997","article-title":"Medical cannabis and cannabinoids in rheumatology: where are we now?","volume":"15","author":"Sarzi-Puttini P","year":"2019","unstructured":"Sarzi-Puttini P, Batticciotto A, Atzeni F, et al.. Medical cannabis and cannabinoids in rheumatology: where are we now?. Expert Rev Clin Immunol. 2019, 15:1019-32. 10.1080\/1744666X.2019.1665997","journal-title":"Expert Rev Clin Immunol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102409","article-title":"Cannabinoids in the treatment of rheumatic diseases: pros and cons","volume":"18","author":"Sarzi-Puttini P","year":"2019","unstructured":"Sarzi-Puttini P, Ablin J, Trabelsi A, Fitzcharles MA, Marotto D, H\u00e4user W. Cannabinoids in the treatment of rheumatic diseases: pros and cons. Autoimmun Rev. 2019, 18:102409. 10.1016\/j.autrev.2019.102409","journal-title":"Autoimmun Rev"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01602-1","article-title":"Cannabis-based medicines and medical cannabis in the treatment of nociplastic pain","volume":"81","author":"Fitzcharles MA","year":"2021","unstructured":"Fitzcharles MA, Petzke F, T\u00f6lle TR, H\u00e4user W. Cannabis-based medicines and medical cannabis in the treatment of nociplastic pain. Drugs. 2021, 81:2103-16. 10.1007\/s40265-021-01602-1","journal-title":"Drugs"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1089\/can.2021.0156","article-title":"Clinical practice guidelines for cannabis and cannabinoid-based medicines in the management of chronic pain and co-occurring conditions","author":"Bell AD","year":"2023","unstructured":"Bell AD, MacCallum C, Margolese S, et al.. Clinical practice guidelines for cannabis and cannabinoid-based medicines in the management of chronic pain and co-occurring conditions. Cannabis Cannabinoid Res. 2023, 10.1089\/can.2021.0156","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108216","article-title":"Cannabinoids and the endocannabinoid system in fibromyalgia: a review of preclinical and clinical research","volume":"240","author":"Bourke SL","year":"2022","unstructured":"Bourke SL, Schlag AK, O'Sullivan SE, Nutt DJ, Finn DP. Cannabinoids and the endocannabinoid system in fibromyalgia: a review of preclinical and clinical research. Pharmacol Ther. 2022, 240:108216. 10.1016\/j.pharmthera.2022.108216","journal-title":"Pharmacol Ther"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17332","article-title":"A systematic review of fibromyalgia and recent advancements in treatment: is medicinal cannabis a new hope?","volume":"13","author":"Khurshid H","year":"2021","unstructured":"Khurshid H, Qureshi IA, Jahan N, Went TR, Sultan W, Sapkota A, Alfonso M. A systematic review of fibromyalgia and recent advancements in treatment: is medicinal cannabis a new hope?. Cureus. 2021, 13:e17332. 10.7759\/cureus.17332","journal-title":"Cureus"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010015","article-title":"Cannabis use, cannabis use disorder, and comorbid psychiatric illness: a narrative review","volume":"10","author":"Hasin D","year":"2021","unstructured":"Hasin D, Walsh C. Cannabis use, cannabis use disorder, and comorbid psychiatric illness: a narrative review. J Clin Med. 2021, 10:15. 10.3390\/jcm10010015","journal-title":"J Clin Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-012-2077-6","article-title":"Shared decision making: a model for clinical practice","volume":"27","author":"Elwyn G","year":"2012","unstructured":"Elwyn G, Frosch D, Thomson R, et al.. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012, 27:1361-7. 10.1007\/s11606-012-2077-6","journal-title":"J Gen Intern Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001870","article-title":"\"No one wants to look after the fibro patient\". Understanding models, and patient perspectives, of care for fibromyalgia: reviews of current evidence","volume":"161","author":"Doebl S","year":"2020","unstructured":"Doebl S, Macfarlane GJ, Hollick RJ. \"No one wants to look after the fibro patient\". Understanding models, and patient perspectives, of care for fibromyalgia: reviews of current evidence. Pain. 2020, 161:1716-25. 10.1097\/j.pain.0000000000001870","journal-title":"Pain"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.02.005","article-title":"Progress towards improved non-pharmacological management of fibromyalgia","volume":"87","author":"Pinto AM","year":"2020","unstructured":"Pinto AM, Geenen R, Castilho P, da Silva JA. Progress towards improved non-pharmacological management of fibromyalgia. Joint Bone Spine. 2020, 87:377-9. 10.1016\/j.jbspin.2020.02.005","journal-title":"Joint Bone Spine"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-05025-9","article-title":"Dosage of resistance exercises in fibromyalgia: evidence synthesis for a systematic literature review up-date and meta-analysis","volume":"42","author":"da Silva JM","year":"2022","unstructured":"da Silva JM, de Barros BS, Almeida GJ, O'Neil J, Imoto AM. Dosage of resistance exercises in fibromyalgia: evidence synthesis for a systematic literature review up-date and meta-analysis. Rheumatol Int. 2022, 42:413-29. 10.1007\/s00296-021-05025-9","journal-title":"Rheumatol Int"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00873-6","article-title":"Emotion regulation and the salience network: a hypothetical integrative model of fibromyalgia","volume":"19","author":"Pinto AM","year":"2023","unstructured":"Pinto AM, Geenen R, Wager TD, et al.. Emotion regulation and the salience network: a hypothetical integrative model of fibromyalgia. Nat Rev Rheumatol. 2023, 19:44-60. 10.1038\/s41584-022-00873-6","journal-title":"Nat Rev Rheumatol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1121","article-title":"Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome - a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Bernardy K","year":"2018","unstructured":"Bernardy K, Klose P, Welsch P, H\u00e4user W. Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome - a systematic review and meta-analysis of randomized controlled trials. Eur J Pain. 2018, 22:242-60. 10.1002\/ejp.1121","journal-title":"Eur J Pain"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijchp.2020.04.002","article-title":"Combined cognitive-behavioral therapy for fibromyalgia: effects on polysomnographic parameters and perceived sleep quality","volume":"20","author":"Prados G","year":"2020","unstructured":"Prados G, Mir\u00f3 E, Mart\u00ednez MP, S\u00e1nchez AI, Lami MJ, C\u00e1liz R. Combined cognitive-behavioral therapy for fibromyalgia: effects on polysomnographic parameters and perceived sleep quality. Int J Clin Health Psychol. 2020, 20:232-42. 10.1016\/j.ijchp.2020.04.002","journal-title":"Int J Clin Health Psychol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctcp.2020.101255","article-title":"Partially randomized patient preference trial: comparative evaluation of fibromyalgia between acupuncture and cupping therapy (PRPP-FACT)","volume":"41","author":"Cao HJ","year":"2020","unstructured":"Cao HJ, Zhang YJ, Zhou L, et al.. Partially randomized patient preference trial: comparative evaluation of fibromyalgia between acupuncture and cupping therapy (PRPP-FACT). Complement Ther Clin Pract. 2020, 41:101255. 10.1016\/j.ctcp.2020.101255","journal-title":"Complement Ther Clin Pract"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1159\/000329329","article-title":"Medicinal cupping therapy in 30 patients with fibromyalgia: a case series observation","volume":"18","author":"Cao H","year":"2011","unstructured":"Cao H, Hu H, Colagiuri B, Liu J. Medicinal cupping therapy in 30 patients with fibromyalgia: a case series observation. Forsch Komplementmed. 2011, 18:122-6. 10.1159\/000329329","journal-title":"Forsch Komplementmed"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2009.0599","article-title":"Traditional Chinese Medicine for treatment of fibromyalgia: a systematic review of randomized controlled trials","volume":"16","author":"Cao H","year":"2010","unstructured":"Cao H, Liu J, Lewith GT. Traditional Chinese Medicine for treatment of fibromyalgia: a systematic review of randomized controlled trials. J Altern Complement Med. 2010, 16:397-409. 10.1089\/acm.2009.0599","journal-title":"J Altern Complement Med"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.explore.2015.12.003","article-title":"An integrated methodology to assess compliance with Delphi survey key components of yoga interventions for musculoskeletal conditions as applied in a systematic review of fibromyalgia studies","volume":"12","author":"Fischer-White TG","year":"2016","unstructured":"Fischer-White TG, Anderson JG, Taylor AG. An integrated methodology to assess compliance with Delphi survey key components of yoga interventions for musculoskeletal conditions as applied in a systematic review of fibromyalgia studies. Explore (NY). 2016, 12:100-12. 10.1016\/j.explore.2015.12.003","journal-title":"Explore (NY)"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.52965\/001c.25085","article-title":"Efficacy of acupuncture in the treatment of fibromyalgia","volume":"13","author":"Berger AA","year":"2021","unstructured":"Berger AA, Liu Y, Nguyen J, et al.. Efficacy of acupuncture in the treatment of fibromyalgia. Orthop Rev (Pavia). 2021, 13:25085. 10.52965\/001c.25085","journal-title":"Orthop Rev (Pavia)"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2020.01.003","article-title":"Is transcranial direct current stimulation (tDCS) effective for the treatment of pain in fibromyalgia? A systematic review and meta-analysis","volume":"21","author":"Lloyd DM","year":"2020","unstructured":"Lloyd DM, Wittkopf PG, Arendsen LJ, Jones AK. Is transcranial direct current stimulation (tDCS) effective for the treatment of pain in fibromyalgia? A systematic review and meta-analysis. J Pain. 2020, 21:1085-100. 10.1016\/j.jpain.2020.01.003","journal-title":"J Pain"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092664","article-title":"Dietary interventions in the management of fibromyalgia: a systematic review and best-evidence synthesis","volume":"12","author":"Lowry E","year":"2020","unstructured":"Lowry E, Marley J, McVeigh JG, McSorley E, Allsopp P, Kerr D. Dietary interventions in the management of fibromyalgia: a systematic review and best-evidence synthesis. Nutrients. 2020, 12:2664. 10.3390\/nu12092664","journal-title":"Nutrients"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092525","article-title":"Nutritional interventions in the management of fibromyalgia syndrome","volume":"12","author":"Pagliai G","year":"2020","unstructured":"Pagliai G, Giangrandi I, Dinu M, Sofi F, Colombini B. Nutritional interventions in the management of fibromyalgia syndrome. Nutrients. 2020, 12:2525. 10.3390\/nu12092525","journal-title":"Nutrients"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.856216","article-title":"An anti-inflammatory and low fermentable oligo, di, and monosaccharides and polyols diet improved patient reported outcomes in fibromyalgia: a randomized controlled trial","volume":"9","author":"Silva AR","year":"2022","unstructured":"Silva AR, Bernardo A, de Mesquita MF, Vaz-Patto J, Moreira P, Silva ML, Padr\u00e3o P. An anti-inflammatory and low fermentable oligo, di, and monosaccharides and polyols diet improved patient reported outcomes in fibromyalgia: a randomized controlled trial. Front Nutr. 2022, 9:856216. 10.3389\/fnut.2022.856216","journal-title":"Front Nutr"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3390\/nu15030716","article-title":"Dietary effects on pain symptoms in patients with fibromyalgia syndrome: systematic review and future directions","volume":"15","author":"Maddox EK","year":"2023","unstructured":"Maddox EK, Massoni SC, Hoffart CM, Takata Y. Dietary effects on pain symptoms in patients with fibromyalgia syndrome: systematic review and future directions. Nutrients. 2023, 15:716. 10.3390\/nu15030716","journal-title":"Nutrients"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/742510","article-title":"Patients' and professionals' views on managing fibromyalgia","volume":"18","author":"Briones-Vozmediano E","year":"2013","unstructured":"Briones-Vozmediano E, Vives-Cases C, Ronda-P\u00e9rez E, Gil-Gonz\u00e1lez D. Patients' and professionals' views on managing fibromyalgia. Pain Res Manag. 2013, 18:19-24. 10.1155\/2013\/742510","journal-title":"Pain Res Manag"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/pzab200","article-title":"Effectiveness of a multicomponent treatment based on pain neuroscience education, therapeutic exercise, cognitive behavioral therapy, and mindfulness in patients with fibromyalgia (FIBROWALK study): a randomized controlled trial","volume":"101","author":"Serrat M","year":"2021","unstructured":"Serrat M, Sanabria-Mazo JP, Almirall M, et al.. Effectiveness of a multicomponent treatment based on pain neuroscience education, therapeutic exercise, cognitive behavioral therapy, and mindfulness in patients with fibromyalgia (FIBROWALK study): a randomized controlled trial. Phys Ther. 2021, 101:pzab200. 10.1093\/ptj\/pzab200","journal-title":"Phys Ther"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201249","article-title":"Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis","volume":"72","author":"N\u00fcesch E","year":"2013","unstructured":"N\u00fcesch E, H\u00e4user W, Bernardy K, Barth J, J\u00fcni P. Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis. 2013, 72:955-62. 10.1136\/annrheumdis-2011-201249","journal-title":"Ann Rheum Dis"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1080\/09638288.2018.1543361","article-title":"A 12-week multicomponent therapy in fibromyalgia improves health but not in concomitant moderate depression, an exploratory pilot study","volume":"42","author":"Ollevier A","year":"2020","unstructured":"Ollevier A, Vanneuville I, Carron P, Baetens T, Goderis T, Gabriel L, Van de Velde D. A 12-week multicomponent therapy in fibromyalgia improves health but not in concomitant moderate depression, an exploratory pilot study. Disabil Rehabil. 2020, 42:1886-93. 10.1080\/09638288.2018.1543361","journal-title":"Disabil Rehabil"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110277","article-title":"Toward development of a fibromyalgia responder index and disease activity score: OMERACT module update","volume":"38","author":"Mease PJ","year":"2011","unstructured":"Mease PJ, Clauw DJ, Christensen R, et al.. Toward development of a fibromyalgia responder index and disease activity score: OMERACT module update. J Rheumatol. 2011, 38:1487-95. 10.3899\/jrheum.110277","journal-title":"J Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/183881-is-fibromyalgia-a-fashionable-diagnosis-or-a-medical-mystery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:04:40Z","timestamp":1707491080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/183881-is-fibromyalgia-a-fashionable-diagnosis-or-a-medical-mystery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":88,"URL":"https:\/\/doi.org\/10.7759\/cureus.44852","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,7]]}}}